FDA Warns Compounders for Poor Quality and Unapproved Drugs

Drug Industry Daily
A A
The FDA has cited two compounding pharmacies for making unapproved and contaminated drugs, and for poor sterile processing practices, the latest indication that the agency won’t let up on larger facilities.

To View This Article:

Login

Subscribe To Drug Industry Daily